Search Results

There are 4928 results for: content related to: Effect of peginterferon alfa-2a (40 KD ) on cytochrome P 450 isoenzyme activity

  1. You have full text access to this OnlineOpen article
    Pharmacokinetics and response of obese patients with chronic hepatitis C treated with different doses of PEG-IFN α-2a (40KD) (PEGASYS®)

    British Journal of Clinical Pharmacology

    Volume 67, Issue 3, March 2009, Pages: 280–287, Brian Bressler, Ka Wang, Joseph F. Grippo and E. Jenny Heathcote

    Article first published online : 20 MAR 2009, DOI: 10.1111/j.1365-2125.2008.03349.x

  2. You have full text access to this OnlineOpen article
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Article first published online : 5 OCT 2005, DOI: 10.1002/hep.20927

  3. You have full text access to this OnlineOpen article
    Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: Randomized study of higher doses of peginterferon α-2a and ribavirin

    Hepatology

    Volume 48, Issue 4, October 2008, Pages: 1033–1043, Michael W. Fried, Donald M. Jensen, Maribel Rodriguez-Torres, Lisa M. Nyberg, Adrian M. Di Bisceglie, Timothy R. Morgan, Paul J. Pockros, Amy Lin, Lisa Cupelli, Frank Duff, Ka Wang and David R. Nelson

    Article first published online : 9 JUN 2008, DOI: 10.1002/hep.22448

  4. You have full text access to this OnlineOpen article
    Insulin at normal physiological levels does not prolong QTc interval in thorough QT studies performed in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 75, Issue 2, February 2013, Pages: 392–403, Jorg Taubel, Ulrike Lorch, Georg Ferber, Jatinder Singh, Velislav N. Batchvarov, Irina Savelieva and A. John Camm

    Article first published online : 10 JAN 2013, DOI: 10.1111/j.1365-2125.2012.04376.x

  5. You have full text access to this OnlineOpen article
    Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 388–397, Savino Bruno, Mitchell L. Shiffman, Stuart K. Roberts, Edward J. Gane, Diethelm Messinger, Stephanos J. Hadziyannis and Patrick Marcellin

    Article first published online : 29 SEP 2009, DOI: 10.1002/hep.23340

  6. You have full text access to this OnlineOpen article
    Abstracts 259 to 542

    Hepatology

    Volume 44, Issue S1, October 2006, Pages: 287A–390A,

    Article first published online : 25 SEP 2006, DOI: 10.1002/hep.21396

  7. You have full text access to this OnlineOpen article
    AASLD Abstracts (pp. 687A–784A)

    Hepatology

    Volume 38, Issue S4, October 2003, Pages: 687A–784A,

    Article first published online : 10 FEB 2006, DOI: 10.1002/hep.1840380509

  8. You have full text access to this OnlineOpen article
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Article first published online : 19 SEP 2007, DOI: 10.1002/hep.22017

  9. Optimal dose of peginterferon and ribavirin for treatment of chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 15, Issue 9, September 2008, Pages: 623–633, M. Gambarin-Gelwan and I. M. Jacobson

    Article first published online : 10 JUL 2008, DOI: 10.1111/j.1365-2893.2008.01018.x

  10. You have full text access to this OnlineOpen article
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  11. Understanding the effect of the HCV polymerase inhibitor mericitabine on early viral kinetics in the phase 2 JUMP-C and PROPEL studies

    British Journal of Clinical Pharmacology

    Accepted manuscript online: 6 MAR 2014, Ya-Chi Chen, Coen Bernaards, Rohit Kulkarni, Sebastian Moreira, Yonghong Zhu, Anna Chan, Ethan Badman, Andrew Ackrill, James Thommes and Patrick F. Smith

    DOI: 10.1111/bcp.12369

  12. You have full text access to this OnlineOpen article
    Review article: the role of rapid virological response in determining treatment duration for chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1251–1267, F. F. POORDAD

    Article first published online : 17 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04300.x

  13. You have free access to this content
    Poster Sessions

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 92A–207A,

    Article first published online : 1 OCT 2013, DOI: 10.1002/hep.26726

  14. You have full text access to this OnlineOpen article
    AASLD Abstracts 1606–1960

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 1019A–1187A,

    Article first published online : 24 SEP 2008, DOI: 10.1002/hep.22647

  15. You have full text access to this OnlineOpen article
    AASLD Abstracts (pp. 282A–382A)

    Hepatology

    Volume 38, Issue S4, October 2003, Pages: 282A–382A,

    Article first published online : 10 FEB 2006, DOI: 10.1002/hep.1840380505

  16. You have free access to this content
    Translation Section

    British Journal of Clinical Pharmacology

    Volume 75, Issue 2, February 2013, Pages: 574–584,

    Article first published online : 10 JAN 2013, DOI: 10.1111/bcp.12029

  17. You have full text access to this OnlineOpen article
    Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet?

    British Journal of Clinical Pharmacology

    Volume 75, Issue 4, April 2013, Pages: 885–896, Richard Kia, Rowena L. C. Sison, James Heslop, Neil R. Kitteringham, Neil Hanley, John S. Mills, B. Kevin Park and Chris E. P. Goldring

    Article first published online : 15 MAR 2013, DOI: 10.1111/j.1365-2125.2012.04360.x

  18. You have full text access to this OnlineOpen article
    Safe prescribing: a titanic challenge

    British Journal of Clinical Pharmacology

    Volume 74, Issue 4, October 2012, Pages: 676–684, Philip A. Routledge

    Article first published online : 5 SEP 2012, DOI: 10.1111/j.1365-2125.2012.04367.x

  19. You have full text access to this OnlineOpen article
    Observational study on safety and tolerability of duloxetine in the treatment of female stress urinary incontinence in German routine practice

    British Journal of Clinical Pharmacology

    Volume 75, Issue 4, April 2013, Pages: 1098–1108, Martin C. Michel, Anette Minarzyk, Inka Schwerdtner, Deborah Quail, Hans D. Methfessel and Hans-Joachim Weber

    Article first published online : 15 MAR 2013, DOI: 10.1111/j.1365-2125.2012.04389.x

  20. You have full text access to this OnlineOpen article
    Pharmacogenomics of warfarin in populations of African descent

    British Journal of Clinical Pharmacology

    Volume 75, Issue 2, February 2013, Pages: 334–346, Guilherme Suarez-Kurtz and Mariana R. Botton

    Article first published online : 10 JAN 2013, DOI: 10.1111/j.1365-2125.2012.04354.x